MARKET

GOVXW

GOVXW

Geovax Labs Inc
NASDAQ
0.0312
-0.0124
-28.36%
Closed 15:33 05/13 EDT
OPEN
0.0450
PREV CLOSE
0.0436
HIGH
0.0450
LOW
0.0311
VOLUME
4.65K
TURNOVER
--
52 WEEK HIGH
0.6500
52 WEEK LOW
0.0141
MARKET CAP
--
P/E (TTM)
-0.0074
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at GOVXW last week (0505-0509)?
Weekly Report · 1d ago
Weekly Report: what happened at GOVXW last week (0428-0502)?
Weekly Report · 05/05 09:50
Geovax highlights progress on mpox vaccine and COVID-19 trial advancements
Seeking Alpha · 05/02 00:59
Weekly Report: what happened at GOVXW last week (0421-0425)?
Weekly Report · 04/28 09:54
Weekly Report: what happened at GOVXW last week (0414-0418)?
Weekly Report · 04/21 09:54
GEOVAX LABS INC <GOVX.O>: ALLIANCE GLOBAL PARTNERS CUTS TARGET PRICE TO $8.5 FROM $15
Reuters · 04/15 11:20
U.S. RESEARCH ROUNDUP- CNB Financial, Disney, Triumph Group
Reuters · 04/15 07:16
BUZZ-GeoVax tumbles as HHS ends mid-stage COVID vaccine trial
Reuters · 04/14 21:02
More
About GOVXW
GeoVax Labs, Inc. is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using proprietary platforms. Its product pipeline includes ongoing human clinical trials for a Covid-19 vaccine and a gene-directed therapy against advanced head and neck cancers. Its additional research and development programs include preventive vaccines against Mpox and smallpox, hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan and Marburg), Zika virus and malaria, as well as immunotherapies for multiple solid tumors. The Company’s portfolio of wholly owned, co-owned, and in-licensed intellectual property, stands at over 155 granted or pending patent applications spread over 24 patent families. Its product candidate includes GEO-CM04S1, GEO-CM02, Gedeptin, MVA-VLP-MUC1, GEO-ZM02 and others. Its lead infectious disease candidate is GEO-CM04S1, a COVID-19 vaccine targeting high-risk immunocompromised patient populations.

Webull offers Geovax Labs Inc stock information, including NASDAQ: GOVXW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GOVXW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GOVXW stock methods without spending real money on the virtual paper trading platform.